These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 21529896

  • 1. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L, Decavele AS, Schouwers S, Devreese K.
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS, Schouwers S, Devreese KM.
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [Abstract] [Full Text] [Related]

  • 3. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F, Persijn L, Decavele AS, Devreese K.
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D, Alessio MG, Tampoia M, Da Re A, Stella S, Da Re M, Tozzoli R, Bizzaro N.
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y, Shida H, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2014 Sep; 37(5):430-6. PubMed ID: 25744643
    [Abstract] [Full Text] [Related]

  • 6. Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A, Gris JC, Moore GW, Musiał J, Zuily S, Wahl D, Devreese KMJ.
    J Thromb Haemost; 2024 Aug; 22(8):2345-2362. PubMed ID: 38704123
    [Abstract] [Full Text] [Related]

  • 7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 8. Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.
    Janek D, Slavik L, Ulehlova J, Krcova V, Hlusi A, Prochazkova J.
    Clin Lab; 2016 Jul 01; 62(7):1309-1315. PubMed ID: 28164648
    [Abstract] [Full Text] [Related]

  • 9. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.
    Int J Clin Exp Pathol; 2012 Jul 01; 5(3):210-5. PubMed ID: 22558475
    [Abstract] [Full Text] [Related]

  • 10. Detection of antiphospholipid antibodies by automated chemiluminescence assay.
    Capozzi A, Lococo E, Grasso M, Longo A, Garofalo T, Misasi R, Sorice M.
    J Immunol Methods; 2012 May 31; 379(1-2):48-52. PubMed ID: 22421684
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G, Teodorescu M.
    Lupus; 2011 May 31; 20(6):614-9. PubMed ID: 21436214
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr 31; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W, Kelchtermans H, Moore GW, Musiał J, Wahl D, de Laat B, Devreese KMJ.
    J Thromb Haemost; 2018 Oct 31; 16(10):2016-2023. PubMed ID: 30079628
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA, Chang Y, Pierangeli SS, Harris EN, Polisson RP.
    J Rheumatol; 1999 Mar 31; 26(3):591-6. PubMed ID: 10090168
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.
    Clin Exp Immunol; 2015 May 31; 180(2):218-26. PubMed ID: 25522978
    [Abstract] [Full Text] [Related]

  • 20. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A, Italian Federation of Anticoagulation Clinics (FCSA).
    Thromb Res; 2007 May 31; 120(1):127-33. PubMed ID: 17020782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.